You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for New Drug Application (NDA): 022368


✉ Email this page to a colleague

« Back to Dashboard


NDA 022368 describes ARIDOL KIT, which is a drug marketed by Pharmaxis Europe and is included in one NDA. It is available from one supplier. Additional details are available on the ARIDOL KIT profile page.

The generic ingredient in ARIDOL KIT is mannitol. There are eighteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the mannitol profile page.
Summary for 022368
Tradename:ARIDOL KIT
Applicant:Pharmaxis Europe
Ingredient:mannitol
Patents:0
Medical Subject Heading (MeSH) Categories for 022368
Suppliers and Packaging for NDA: 022368
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ARIDOL KIT mannitol POWDER;INHALATION 022368 NDA Methapharm, Inc. 67850-552 67850-552-01 1 KIT in 1 KIT (67850-552-01) * 1 POWDER in 1 CAPSULE * 1 POWDER in 1 KIT * 1 POWDER in 1 KIT * 1 POWDER in 1 KIT

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;INHALATIONStrengthN/A,5MG,10MG,20MG,40MG
Approval Date:Oct 5, 2010TE:RLD:Yes

Expired US Patents for NDA 022368

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmaxis Europe ARIDOL KIT mannitol POWDER;INHALATION 022368-001 Oct 5, 2010 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.